Affordable Access

Psychiatric drug trials and placebo.

Authors
Type
Published Article
Journal
Nordic journal of psychiatry
Publication Date
Volume
59
Issue
4
Pages
233–237
Identifiers
PMID: 16195126
Source
Medline
License
Unknown

Abstract

The placebo-controlled trial has been the standard method to demonstrate efficacy and safety of drugs. The trials are regulated by standards and principles that aim to safeguard patient safety and to ensure the faultless availability of reliable information about the object of the survey. The use of a placebo group in clinical drug trials is still as well founded as ever, and is especially important in conditions where the severity of the disorder is associated with variation in time, the possibility of a spontaneous recovery, or in conditions involving a significant proportion of subjective experience. In this systematic review, the present guidelines for developing new compounds for psychiatric disorders are discussed.

Statistics

Seen <100 times